|
|
Last Modified: 1/13/2009  First Published: 1/1/2001 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Prevention
|
|
|
|
Active
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
ECOG-5597 CAN-NCIC-BR16, CALGB-79803, NCCTG-E5597, SWOG-E5597, NCI-P00-0176, NCT00008385, BR16
|
|
|
|
|
|
|
|
Last Modified: 11/18/2008  First Published: 5/28/2004 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Prevention
|
|
|
|
Active
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
UCHSC-01279 NCT00084409
|
|
|
|
|
|
|
|
Last Modified: 6/10/2008  First Published: 8/6/2006 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Biomarker/Laboratory analysis, Prevention
|
|
|
|
Active
|
|
|
|
40 to 80
|
|
|
|
NCI
|
|
|
|
UARIZ-HSC-0353 U01-CA-101204, NCT00363805
|
|
|
|
|
|
|
|
Last Modified: 12/3/2008  First Published: 8/18/2006 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Biomarker/Laboratory analysis, Prevention
|
|
|
|
Active
|
|
|
|
40 to 79
|
|
|
|
NCI
|
|
|
|
MAYO-03-1-02 MAY03-1-02, NCT00368927
|
|
|
|
|
|
|
|
Last Modified: 12/5/2008  First Published: 10/6/2006 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Biomarker/Laboratory analysis, Prevention
|
|
|
|
Active
|
|
|
|
45 and over
|
|
|
|
NCI, Pharmaceutical / Industry
|
|
|
|
MCC-14787 MCC-104545, LILLY-H6Q-MC-S009A, U01-CA-101222, NCT00387816
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Prevention
|
|
|
|
Active
|
|
|
|
45 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
10723 H6Q-MC-S009, NCT00414960
|
|
|
|
|
|
|
|
Last Modified: 4/24/2008  First Published: 2/7/2008 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Biomarker/Laboratory analysis, Prevention
|
|
|
|
Active
|
|
|
|
45 to 74
|
|
|
|
NCI
|
|
|
|
BCCA-H07-02401 H07-02401, NCT00611650
|
|
|
|
|
|
|
|
Last Modified: 11/4/2008  First Published: 10/30/2008 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Biomarker/Laboratory analysis, Prevention
|
|
|
|
Active
|
|
|
|
45 to 79
|
|
|
|
NCI
|
|
|
|
MAYO-MAY06-8-01 MAY06-8-01, NCT00783705
|
|
|
|
|
|
|
|
Last Modified: 5/31/2008  First Published: 11/10/2005 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Prevention
|
|
|
|
Active
|
|
|
|
Over 18
|
|
|
|
NCI
|
|
|
|
JHOC-J0427 JHOC-04051801, NCT00255775
|
|
|
|
|
|
|
|
Last Modified: 9/15/2008  First Published: 4/23/2008 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Behavioral study, Biomarker/Laboratory analysis, Educational/Counseling/Training, Prevention
|
|
|
|
Active
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
KUMC-HSC-10332 10332, KUMC-070313, NCT00666978
|
|
|
|